MBBS (Singapore), MRCS (Edinburgh), MMed
(Surgery, Singapore), FRCS (Edinburgh)
Specialty: General Surgery
Sub-specialties: Breast Surgery, Oncoplastic Breast Surgery
Conditions Treated by this Doctor:
3D-breast Tomosynthesis, Atypical Hyperplasia, Benign Breast Change and Symptoms, Benign Breast Diseases, Benign Breast Neoplasms, Breast Cancer , Breast Cancer - Diagnosis to Treatment, Breast Cancer - Early Detection and Screening, Breast Cancer (Breast Health), Breast Clinical Assessment, Breast Infection, Breast Lumps, Breast Radiological Evaluation, Breast Reconstruction, Breast Surgery, Duct Ectasia, Early and Advanced Breast Cancer, Fibroadenoma, Fibrocystic Change, Gynaecomastia, Hereditary Breast Cancer Syndromes, High Risk Breast Changes, Intraductal Papillomas, Lobular Carcinoma in Situ, Malignant and Benign Breast Conditions, Mastitis.
Dr Chua Hui Wen is a Consultant in Breast Surgery, Department of Surgery, Sengkang General Hospital. She is a member of the Singhealth Duke-NUS Breast Centre. She performs general surgery including minimally invasive procedures, and breast oncoplastic surgery. Her practice involves both benign breast disease and also the screening, diagnosis and management of breast cancer. She advocates for holistic and personalized treatments for each individual patient after in-depth consultations. She believes in working closely alongside patients and other professionals in a multi-disciplinary team to create the best treatment plan for patients, targeting key areas ranging from clinical to psycho-social aspects.
Dr Chua Hui Wen graduated from Yong Loo Lin School of Medicine, National University of Singapore (NUS) in 2012, and received her formal general surgery and initial breast subspecialist residency training in National University Hospital of Singapore (NUHS) from 2013 to 2018. In this period she completed her membership examination of the Royal College of Surgeons of Edinburgh (Surgery) in 2014, and obtained the Master of Medicine (Surgery) from the National University of Singapore in 2017. She became a Fellow of the Royal College of Surgeons of Edinburgh (General Surgery) in 2018, after passing her exit examinations and completed residency training.
She practices at Sengkang Hospital's department of general surgery, adept at minimally invasive surgeries for hernias and cholecystectomies. She subspecialises in breast and oncoplastic surgery. Young women with breast cancer is a key research area for Dr Chua as these patients bear significant socioeconomic impact, being in their reproductive years and are major contributors to the productive workforce. She is passionate about improving the quality of care including genetic testing and fertility preservation, alongside oncological treatment. She is also heavily involved in medical student and postgraduate residency education, being the education lead for Yong Loo Lin School of Medicine Phase III students. She has embarked on several quality improvement projects for the hospital, to reduce bed crunch and increase the efficiency of day surgery.
1) Ngaserin S, Chua HW, Chew MH, Tan BKT. A tripartite approach can seek to optimize breast cancer management during a pandemic - Real-Time experience of a developing breast oncology unit in Singapore. Breast J. 2020;10.1111/tbj.13961. doi:10.1111/tbj.13961
2) S Ngaserin, HW Chua, TM Mipuri
FDG-PET/CT unilateral breast enlargement and diffuse hypermetabolism related to unilateral lactation in a patient with primary biliary cirrhosis.
Breast J. May 2020; 10.111/tbj.13906.doi:10.111/tbj.13906
3) QT Teo, HW Chua, T Kabir
Not your usual painful groin lump: De Garengeot's Hernia
Clinical Gastroenterology and Hepatology May 2020. https//doi.org/10.1016/j.cgh.2020.05.006
4) Chua HW, Zhou HJ, Khoo CM, Shabbir A, Lomanto D, So JB.
Attitudes and Concerns of Diabetic patients towards Bariatric Surgery as Treatment of Diabetes. Ann Acad Med Singapore 2016 Nov; 45(11):495-506.
Singhealth Joint Breast Cancer Registry - Looking at the demographics, disease characteristics, treatment, compliance and outcomes including genetic counselling and fertility preservation in young women below 40 years old diagnosed with breast cancer.
Subscribe to our mailing list to get the updates to your inbox